Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection

MLA

Yu-Feng Zhou, et al. “Linezolid and Rifampicin Combination to Combat Cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection.” Frontiers in Microbiology, vol. 10, Jan. 2020. EBSCOhost, https://doi.org/10.3389/fmicb.2019.03080.

APA

Yu-Feng Zhou, Liang Li, Meng-Ting Tao, Jian Sun, Xiao-Ping Liao, Ya-Hong Liu, & Yan Q. Xiong. (2020). Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection. Frontiers in Microbiology, 10. https://doi.org/10.3389/fmicb.2019.03080

Chicago

Yu-Feng Zhou, Liang Li, Meng-Ting Tao, Jian Sun, Xiao-Ping Liao, Ya-Hong Liu, and Yan Q. Xiong. 2020. “Linezolid and Rifampicin Combination to Combat Cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection.” Frontiers in Microbiology 10 (January). doi:10.3389/fmicb.2019.03080.